Patients were titrated to 12 mg/day (or their individual maximum tolerated dose) during the blinded conversion period, followed by open-label maintenance.
14, 15 Long-term treatment with rifaximin during a ≥24-month, open-label maintenance (OLM) study provided continued protection from HE recurrence, reduced the risk of HE-related hospitalisation, and did not adversely affect patient tolerability.
A maximum perampanel daily dose of 10 or 12 mg/day was reached by 1,122 patients (92.3%), and the mean (± standard deviation [SD]) daily dose across the open-label maintenance period was 10.6 mg (±2.25).
Rifaximin therapy reduced risk of hepatic encephalopathy (HE) recurrence and HE-related hospitalisations during a 6-month, randomised, placebo-controlled trial (RCT) and a 24-month open-label maintenance (OLM) study.
The study consisted of a 9-week open-label transition (TR) phase, a 24-week open-label maintenance phase, a randomized double-blind (DB), placebo-controlled, relapse prevention phase of variable duration, and an optional 52-weeks open-label extension (OLE) phase.
defer.add img); If the battery is labeled as "maintenance free," it is not designed to be opened.
(In one spectacular example, the Tennessee Valley Authority labelled as "routine maintenance" a project that required constructing an entire miniature monorail system).
To describe how a sample of women in the Women's Health Initiative Dietary Modification Trial (WHIDM) labeled a healthy eating pattern and to compare these labels to their dietary maintenance.
We conducted a post hoc analysis of data from a PP study that included a 33-week open-label transition (TR) and maintenance phase; a variable duration, randomized, double-blind (DB), placebo-controlled phase and a 52-week open-label extension (OLE) phase.
